Clorox Company (The) (CLX) Shares Bought by Nomura Holdings Inc.

Nomura Holdings Inc. lifted its holdings in Clorox Company (The) (NYSE:CLX) by 37.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 33,910 shares of the company’s stock after buying an additional 9,254 shares during the quarter. Nomura Holdings Inc.’s holdings in Clorox Company (The) were worth $4,533,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. American Beacon Advisors Inc. acquired a new stake in Clorox Company (The) in the first quarter worth about $104,000. Parkside Financial Bank & Trust increased its position in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after purchasing an additional 29 shares during the period. Valley National Advisers Inc. increased its position in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after purchasing an additional 5 shares during the period. Blue Chip Partners Inc. increased its position in Clorox Company (The) by 3.9% in the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares during the period. Finally, Sun Life Financial INC increased its position in Clorox Company (The) by 10,344.4% in the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after purchasing an additional 931 shares during the period. 71.33% of the stock is owned by institutional investors and hedge funds.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the company earned $1.30 earnings per share. The firm’s revenue was up 2.9% compared to the same quarter last year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.57%. Clorox Company (The)’s dividend payout ratio (DPR) is 63.04%.

A number of brokerages recently commented on CLX. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. Jefferies Group LLC reiterated a “hold” rating and issued a $137.00 price objective (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC reiterated an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BidaskClub lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Finally, Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective for the company in a research report on Tuesday, July 4th. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $127.39.

COPYRIGHT VIOLATION WARNING: This article was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://sportsperspectives.com/2017/10/12/clorox-company-the-clx-shares-bought-by-nomura-holdings-inc.html.

In related news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. Insiders have sold 21,242 shares of company stock valued at $2,944,449 over the last 90 days. 1.00% of the stock is owned by corporate insiders.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply